Understanding how syndecan-1 affects lung fibrosis
Syndecan-1 regulation of lung fibrosis
This study is looking at how a protein called syndecan-1 affects lung scarring, and it's aimed at finding new ways to help people with lung fibrosis feel better by understanding how their lungs get injured and heal.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cedars-Sinai Medical Center NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10891369 on NIH RePORTER |
What this research studies
This research focuses on the role of syndecan-1 in the development of lung fibrosis, a condition characterized by scarring of lung tissue. The principal investigator, Dr. Tanyalak Parimon, will work under the guidance of experienced mentors to explore the biological mechanisms behind lung injury and repair. The research will involve laboratory experiments and collaboration with experts in lung biology and extracellular vesicle research. The ultimate goal is to identify potential new treatments for lung fibrosis by understanding the cellular targets involved.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with lung fibrosis or those at risk of developing this condition.
Not a fit: Patients with lung conditions unrelated to fibrosis or those who do not have a diagnosis of lung disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic options for patients suffering from lung fibrosis.
How similar studies have performed: Previous research has shown promise in understanding the role of syndecan-1 in other conditions, suggesting potential for success in this area as well.
Where this research is happening
Los Angeles, United States
- Cedars-Sinai Medical Center — Los Angeles, United States (Active)
Researchers
- Principal investigator: Parimon, Tanyalak — Cedars-Sinai Medical Center
- Study coordinator: Parimon, Tanyalak
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.